Recruiting studies: Alveolar Rhabdomyosarcoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas
Phase 3 · 1 location(s) · N.N. Petrov National Medical Research Center of Oncology · NCT06669013 Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarc
Phase 3 · 180 location(s) · Children's Oncology Group · NCT05304585 Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
Phase 1/Phase 2 · 1 location(s) · University of Florida · NCT06625190

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.